Dorothea Wunder

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


64 publications

2021 | 2019 | 2018 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2001 | 2000 | 1994 |
2021
 
Cognitive function in association with high estradiol levels resulting from fertility treatment.
Leeners B., Krüger T., Geraedts K., Tronci E., Mancini T., Ille F., Egli M., Röblitz S., Wunder D., Saleh L. et al., 2021/04. Hormones and behavior, 130 p. 104951. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E0D7DDDCF9DB]
2019
 
Ten-year single-centre experience in fertility preservation of 459 patients suffering from acute leukaemia.
Noetzli J., Voruz S., Wunder D., Primi M.P., Spertini O., Blum S., 2019/03. British journal of haematology, 184 (6) pp. 969-973. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9AD1D6CC6F77]
2018
Antibodies to <i>Chlamydia trachomatis</i> and reproductive health issues in women with SLE: a case-control study.
Santos A., Greub G., Aeby S., Wunder D., Pantaleo G., Ribi C., 2018. Lupus science & medicine, 5 (1) pp. e000293. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_B997988DA92E]
2015
 
Ultra-low dose - new approaches in menopausal hormone therapy.
Stute P., Becker H.G., Bitzer J., Chatsiproios D., Luzuy F., von Wolff M., Wunder D., Birkhäuser M., 2015. Climacteric, 18 (2) pp. 182-186. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_664B592993F7]
2014
 
Anxiety and Psychological Stress Before Prenatal Screening in First-Time Mothers Who Conceived Through IVF/ICSI or Spontaneously.
Darwiche J., Lawrence C., Vial Y., Wunder D., Stiefel F., Germond M., Despland J.N., de Roten Y., 2014. Women and Health, 54 (5) pp. 474-485. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_505D0732FF8A]
Effect of embryo culture media on birthweight and length in singleton term infants after IVF-ICSI.
Wunder D., Ballabeni P., Roth-Kleiner M., Primi M.P., Senn A., Chanson A., Germond M., Leyvraz C., 2014. Swiss Medical Weekly, 144 pp. w14038.
[URN][DOI][WoS][Pmid][serval:BIB_333B02D0FD19]
 
Techniques de préservation de la fertilité chez la femme en âge de procréer [Fertility preservation techniques in women of reproductive age ].
Vulliemoz N Complete, Gaitzsch H, Primi M-P, Wunder D, Perey L, Streuli I, 2014. Revue Médicale Suisse, 10 (447) pp. 1961-2, 1964-6, 1968.
[Pmid][serval:BIB_1B626978CDE3]
2013
 
A propos du consensus international 2013 sur le traitement hormonal de la ménopause [The global consensus statement 2013 on menopausal hormone therapy]
Wunder D., Pache T.D., 2013/10/23. Revue medicale suisse, 9 (403) pp. 1950,1952-1953. Peer-reviewed.
[Pmid][serval:BIB_3168390CC695]
 
Augmented epithelial multidrug resistance-associated protein 4 expression in peritoneal endometriosis: regulation by lipoxin A(4).
Gori I., Rodriguez Y., Pellegrini C., Achtari C., Hornung D., Chardonnens E., Wunder D., Fiche M., Canny G.O., 2013. Fertility and Sterility, 99 (7) pp. 1965-73.e2. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2978E38F179E]
 
Détermination de l'antigène HLA-G soluble dans le liquide folliculaire et dans le milieu de culture d'embryons comme indicateur du succès d'un traitement par FIV-ICSI [Soluble human leukocyte antigen-G (sHLA-G) in follicular fluid and embryo culture medium and its impact on pregnancy prediction in IVF-ICSI treatment]
Wunder D.M., Birkhäuser M.H., Bersinger N.A., 2013. Immuno-Analyse et Biologie Spécialisée, 28 (1) pp. 43-50.
[DOI][WoS][serval:BIB_CB658950953B]
Origin and outcome of multiple pregnancies in Bern, Switzerland, 1995-2006 and the current proposal of the Swiss parliament to revise the Swiss law of reproductive medicine: Switzerland quo vadis?
Wunder D., Neurohr E.M., Faouzi M., Birkhäuser M.H., 2013. Swiss Medical Weekly, 143 pp. w13864.
[URN][DOI][WoS][Pmid][serval:BIB_5DC36E134A4E]
Social freezing in Switzerland and worldwide--a blessing for women today?
Wunder D., 2013. Swiss Medical Weekly, 143 pp. w13746.
[URN][DOI][WoS][Pmid][serval:BIB_5CC0C719FF00]
2012
Fertility preservation in cancer patients. Review of the French speaking part of Switzerland and recommendations for different situations.
Wunder D., Perey L., 2012. Swiss Medical Weekly, 142 (w13645) pp. 1-7. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_EBCCB6B1AB1E]
 
Influence de deux milieux séquentiels pour la culture d'embryons sur la production d'hormone gonadotrophine chorionique et de progestérone par des cellules JEG-3 et BeWo [Effects of different embryo development media on hCG and progesterone release by JEG-3 and BeWo cells]
Wunder D., von Wyl S., Bischof P., Baumann M.U., Bersinger N.A., 2012. Immuno-analyse et Biologie Spécialisée, 27 (2) pp. 61-65.
[DOI][WoS][serval:BIB_022758EE99ED]
 
The expression of estrogen receptors as well as GREB1, c-MYC, and cyclin D1, estrogen-regulated genes implicated in proliferation, is increased in peritoneal endometriosis.
Pellegrini C., Gori I., Achtari C., Hornung D., Chardonnens E., Wunder D., Fiche M., Canny G.O., 2012. Fertility and Sterility, 98 (5) pp. 1200-1208. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_EB46B70C5B75]
2011
 
Age-related normograms of serum antimüllerian hormone levels in a population of infertile women: a multicenter study.
Almog B., Shehata F., Suissa S., Holzer H., Shalom-Paz E., La Marca A., Muttukrishna S., Blazar A., Hackett R., Nelson S.M. et al., 2011. Fertility and Sterility, 95 (7) pp. 2359-2363.
[DOI][WoS][Pmid][serval:BIB_1AA57952E347]
 
Increased endometrial placenta growth factor (PLGF) gene expression in women with successful implantation.
Santi A., Felser R.S., Mueller M.D., Wunder D.M., McKinnon B., Bersinger N.A., 2011. Fertility and Sterility, 96 (3) pp. 663-668.
[DOI][WoS][Pmid][serval:BIB_61332DCA4A28]
Pregnancy and reproduction in autoimmune rheumatic diseases.
Ostensen M., Brucato A., Carp H., Chambers C., Dolhain R.J., Doria A., Förger F., Gordon C., Hahn S., Khamashta M. et al., 2011. Rheumatology, 50 (4) pp. 657-664.
[URN][DOI][WoS][Pmid][serval:BIB_3CAB57DB1747]
2010
 
Preimplantation genetic diagnosis (PGD) for HLA typing: bases for setting up an open international collaboration when PGD is not available.
Bellavia M., Von Der Weid N., Peddes C., Jacquemont S., Liebaers I., Hohlfeld P., Wunder-Galié D., de Ziegler D., 2010/08. Fertility and sterility, 94 (3) pp. 1129-1131. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B2127EC736E9]
 
Adiponectin isoform distribution in serum and in follicular fluid of women undergoing treatment by ICSI.
Bersinger N.A., Wunder D.M., 2010/06. Acta obstetricia et gynecologica Scandinavica, 89 (6) pp. 782-788. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7A82BC6793E2]
Coping with an HIV infection. A multicenter qualitative survey on HIV positive adolescents' perceptions of their disease, therapeutic adherence and treatment.
Michaud P.A., Suris J.C., Thomas R., Gnehm H.E., Cheseaux J.J., Swiss HIV Mother+Child Cohort Study (MoCHiV), 2010. Swiss Medical Weekly, 140 (17-18) pp. 247-253. Peer-reviewed.
[URN][WoS][Pmid][serval:BIB_FD97A6B30624]
 
Désir de grossesse après vasectomie: vasovasostomie ou procréation médicalement assistée [New child wish after vasectomy: vasovasostomy or assisted reproductive medicine?].
Mroue S., Delaloye J.F., Wunder D., 2010. Revue Médicale Suisse, 6 (268) pp. 2030-2032. Peer-reviewed.
[Pmid][serval:BIB_8CD8038D2E41]
Fertility and cancer: psychological support in young women who contemplate emergency assisted reproductive technologies (ART) prior to chemo- and/or radiation-therapy.
Besse D., Bellavia M., de Ziegler D., Wunder D., 2010. Swiss Medical Weekly, 140 pp. w13075. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_489C903523FB]
 
L'entretien psychologique systématique pour les couples optant pour l'IAD: huit ans d'expérience clinique dans une législation prévoyant la levée de l'anonymat du donneur
Besse D., Emery M., Wunder-Galié D., Wirthner D., 2010. Andrologie, 20 pp. 25-28.
[DOI][serval:BIB_3BDE1A9B3DA0]
 
Obésité et fertilité ne font pas bon ménage [The impact of obesity on fertility]
Pesant M.H., Wunder D., Pralong F., Giusti V., 2010. Revue Médicale Suisse, 6 (242) pp. 662-665.
[Pmid][serval:BIB_3162589F514F]
2009
 
Cystic fibrosis transmembrane conductance regulator mutations in azoospermic and oligospermic men and their partners.
Gallati S., Hess S., Galié-Wunder D., Berger-Menz E., Böhlen D., 2009. Reproductive Biomedicine Online, 19 (5) pp. 685-694.
[WoS][Pmid][serval:BIB_2E6D47C13016]
 
Fécondation in vitro: intérêt et désavantage du remboursement par l'assurance maladie en Suisse [In-vitro fertilization: advantage and disadvantage of covering the costs of IVF/ICSI by the health insurance in Switzerland]
Wunder-Galié D., Hohlfeld P., de Ziegler D., 2009. Revue Médicale Suisse, 5 (222) pp. 2106-2108, 2110.
[Pmid][serval:BIB_59728BD98A3F]
 
Serum glycodelin pattern during the menstrual cycle in healthy young women.
Bersinger N.A., Birkhäuser M.H., Yared M., Wunder D.M., 2009. Acta Obstetricia et Gynecologica Scandinavica, 88 (11) pp. 1215-1221.
[DOI][WoS][Pmid][serval:BIB_ADA9F6A29A2F]
 
Wie hängt die Belastung durch Infertilität mit Depression zusammen? [How is Distress from Infertility Associated with Depression?]
Hämmerli K., Znoj H., Stoklas C., Wunder D., Perrig-Chiello P., 2009. Geburtshilfe und Frauenheilkunde, 69 (6) pp. 533-536.
[DOI][WoS][serval:BIB_ED35F5CE660E]
2008
 
Androgen and gonadotropin patterns differ in HIV-1-infected men who develop lipoatrophy during antiretroviral therapy: a case-control study.
Wunder D.M., Fux C.A., Bersinger N.A., Mueller N.J., Hirschel B., Cavassini M., Elzi L., Schmid P., Bernasconi E., Mueller B. et al., 2008/07. Hiv Medicine, 9 (6) pp. 427-432. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_585ACA3D4F9E]
 
Long-term safety and effectiveness of ritonavir, nelfinavir, and lopinavir/ritonavir in antiretroviral-experienced HIV-infected children.
Rudin C., Burri M., Shen Y., Rode R., Nadal D., Pediatric Infectious Disease Group of Switzerland, Swiss Mother, Child HIV Cohort Study (MoCHiV), 2008/05. Pediatric Infectious Disease Journal, 27 (5) pp. 431-437. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_851BE6EEEA90]
 
Anti-Müllerian hormone and inhibin B as predictors of pregnancy after treatment by in vitro fertilization/intracytoplasmic sperm injection.
Wunder D.M., Guibourdenche J., Birkhäuser M.H., Bersinger N.A., 2008. Fertility and Sterility, 90 (6) pp. 2203-2210.
[DOI][WoS][Pmid][serval:BIB_8B6E1AD15F3C]
 
Antiretroviral treatment during pregnancy.
Keiser O., Gayet-Ageron A., Rudin C., Brinkhof M.W., Gremlich E., Wunder D., Drack G., Hirschel B., de Tejada B.M., Swiss HIV Cohort Study (SHCS) et al., 2008. Aids, 22 (17) pp. 2323-2330. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_33D3E1868134]
 
Gene expression in cultured endometrium from women with different outcomes following IVF.
Bersinger N.A., Wunder D.M., Birkhäuser M.H., Mueller M.D., 2008. Molecular Human Reproduction, 14 (8) pp. 475-484.
[DOI][WoS][Pmid][serval:BIB_EB8EAFACCE7D]
 
Is screening for fetal anomalies reliable in HIV-infected pregnant women? A multicentre study.
Brossard P., Boulvain M., Coll O., Barlow P., Aebi-Popp K., Bischof P., Martinez de Tejada B., Swiss HIV Cohort Study, Swiss HIV Mother, Child Cohort Study, 2008. Aids, 22 (15) pp. 2013-2017. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_ED0149B4962D]
 
Medroxyprogesterone abrogates the inhibitory effects of estradiol on vascular smooth muscle cells by preventing estradiol metabolism.
Dubey R.K., Jackson E.K., Gillespie D.G., Zacharia L.C., Wunder D., Imthurn B., Rosselli M., 2008. Hypertension, 51 (4) pp. 1197-1202. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DD5FDCA946F0]
 
Psychological interventions for infertile patients: a review of existing research and A new comprehensive approach
Haemmerli K., Znoj H., Burri S., Graf P., Wunder D., Perrig-Chiello P., 2008. Counselling and Psychotherapy Research, 8 (4) pp. 246-252.
[DOI][serval:BIB_A4D7848EFD01]
 
Serum hyperglycosylated human chorionic gonadotropin to predict the gestational outcome in in vitro fertilization/intracytoplasmic sperm injection pregnancies.
Bersinger N.A., Wunder D.M., Nicolas M., Birkhäuser M.H., Porquet D., Guibourdenche J., 2008. Fetal Diagnosis and Therapy, 24 (1) pp. 74-78. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F7D6605B13C1]
 
Statistically significant changes of antimüllerian hormone and inhibin levels during the physiologic menstrual cycle in reproductive age women.
Wunder D.M., Bersinger N.A., Yared M., Kretschmer R., Birkhäuser M.H., 2008. Fertility and Sterility, 89 (4) pp. 927-933.
[DOI][WoS][Pmid][serval:BIB_DCCAA13813FE]
2007
 
Hypogonadism in HIV-1-infected men is common and does not resolve during antiretroviral therapy
Wunder D. M., Bersinger N. A., Fux C. A., Mueller N. J., Hirschel B., Cavassini M., Elzi L., Schmid P., Bernasconi E., Mueller B. et al., 2007. Antiviral Therapy, 12 (2) pp. 261-5.
[WoS][Pmid][serval:BIB_D47EB9F3C085]
 
Measurement of anti-mullerian hormone by Beckman Coulter ELISA and DSL ELISA in assisted reproduction: differences between serum and follicular fluid.
Bersinger N.A., Wunder D., Birkhäuser M.H., Guibourdenche J., 2007. Clinica Chimica Acta, 384 (1-2) pp. 174-175.
[DOI][WoS][Pmid][serval:BIB_36B8EB90D12B]
Semen parameters in a fertile Swiss population.
Crazzolara S., Wunder D., Nägeli E., Bodmer C., Graf S., Birkhäuser M.H., 2007. Swiss Medical Weekly, 137 (11-12) pp. 166-172.
[Pmid][serval:BIB_FACFA4084F5C]
2006
 
Frequency of gynecologic follow-up and cervical cancer screening in the Swiss HIV cohort study
Keiser O., Martinez de Tejada B., Wunder D., Chapuis-Taillard C., Zellweger C., Zinkernagel A. S., Elzi L., Schmid P., Bernasconi E., Aebi-Popp K. et al., 2006/12. Journal of Acquired Immune Deficiency Syndromes, 43 (5) pp. 550-5.
[DOI][WoS][Pmid][serval:BIB_E767AD3DA9AD]
 
Adiponectin as a marker of success in intracytoplasmic sperm injection/embryo transfer cycles.
Bersinger N.A., Birkhäuser M.H., Wunder D.M., 2006. Gynecological Endocrinology, 22 (9) pp. 479-483.
[DOI][WoS][Pmid][serval:BIB_72FEED864DE9]
 
Evaluation of p24-based antiretroviral treatment monitoring in pediatric HIV-1 infection: prediction of the CD4+ T-cell changes between consecutive visits.
Brinkhof M.W., Böni J., Steiner F., Tomasik Z., Nadal D., Schüpbach J., 2006. Journal of Acquired Immune Deficiency Syndromes, 41 (5) pp. 557-562.
[DOI][WoS][Pmid][serval:BIB_AEFEFB16D5E5]
 
Increased ENA-78 in the follicular fluid of patients with endometriosis.
Wunder D.M., Mueller M.D., Birkhäuser M.H., Bersinger N.A., 2006. Acta Obstetricia et Gynecologica Scandinavica, 85 (3) pp. 336-342.
[WoS][Pmid][serval:BIB_898671E43656]
 
PAPP-A and osteoprotegerin, together with interleukin-8 and RANTES, are elevated in the peritoneal fluid of women with endometriosis.
Bersinger N.A., von Roten S., Wunder D.M., Raio L., Dreher E., Mueller M.D., 2006. American Journal of Obstetrics and Gynecology, 195 (1) pp. 103-108.
[DOI][WoS][Pmid][serval:BIB_7DCE41616167]
 
Serum leptin and C-reactive protein levels in the physiological spontaneous menstrual cycle in reproductive age women.
Wunder D.M., Yared M., Bersinger N.A., Widmer D., Kretschmer R., Birkhäuser M.H., 2006. European Journal of Endocrinology, 155 (1) pp. 137-142.
[DOI][WoS][Pmid][serval:BIB_7E4968D3A6EE]
 
Surplus embryos in Switzerland in 2003: legislation and availability of human embryos for research.
Koeferl Puorger U.P., Buergin M., Wunder D., Crazzolara S., Birkhaeuser M.H., 2006. Reproductive Biomedicine Online, 13 (6) pp. 772-777.
[WoS][Pmid][serval:BIB_65346DC575DD]
2005
 
Antiretrovirale Medikamente und Schwangerschaft [Antiretroviral therapy and pregnancy].
Wunder D., Evison J.M., 2005. Therapeutische Umschau. Revue Thérapeutique, 62 (1) pp. 37-42.
[Pmid][serval:BIB_32ECFD3572BC]
 
Concentrations of leptin and C-reactive protein in serum and follicular fluid during assisted reproductive cycles.
Wunder D.M., Kretschmer R., Bersinger N.A., 2005. Human Reproduction, 20 (5) pp. 1266-1271.
[DOI][WoS][Pmid][serval:BIB_A8348C9F9CD7]
 
Concentrations sériques de protéines placentaires au 1er trimestre dans des grossesses monofoetales et multiples après FIV : implications pour le dépistage de la trisomie 21 [First trimester serum concentrations of placental proteins in singleton and multiple IVF pregnancies: implications for Down syndrome screening]
Bersinger N.A., Vanderlick F., Birkhäuser M.H., Janecek P., Wunder D., 2005. Immuno-Analyse et Biologie Spécialisée, 20 (1) pp. 21-27.
[DOI][serval:BIB_CB37D29F932D]
 
Fehlbildungen nach assistierter Reproduktionsmedizin
Wunder D., 2005. Der Gynäkologe, 38 (1) pp. 33-38. Peer-reviewed.
[DOI][serval:BIB_59FF4B94A0EB]
 
Lack of seasonal variations in fertilization, pregnancy and implantation rates in women undergoing IVF.
Wunder D.M., Limoni C., Birkhäuser M.H., Swiss FIVNAT-Group, 2005. Human Reproduction, 20 (11) pp. 3122-3129.
[DOI][WoS][Pmid][serval:BIB_A11729C26249]
 
Plasma leptin levels in men are not related to the development of lipoatrophy during antiretroviral therapy.
Wunder D., Bersinger N.A., Fux C., Weber R., Bernasconi E., Cavassini M., Bucher H.C., Schiffer V., Schmid P., Furrer H. et al., 2005. Aids, 19 (16) pp. 1837-1842.
[DOI][WoS][Pmid][serval:BIB_5AF92BC67164]
 
Steroids and protein markers in the follicular fluid as indicators of oocyte quality in patients with and without endometriosis.
Wunder D.M., Mueller M.D., Birkhäuser M.H., Bersinger N.A., 2005. Journal of Assisted Reproduction and Genetics, 22 (6) pp. 257-264.
[WoS][Pmid][serval:BIB_1BB12DC25CA6]
 
Ten years of Swiss National IVF Register FIVNAT-CH. Are we making progress?
Van den Bergh M., Hohl M.K., De Geyter C., Stalberg A.M., Limoni C., 2005. Reproductive Biomedicine Online, 11 (5) pp. 632-640.
[WoS][Pmid][serval:BIB_0BE400CFE933]
2004
 
Maternal serum levels of placental proteins after in vitro fertilisation and their implications for prenatal screening.
Bersinger N.A., Wunder D., Vanderlick F., Chanson A., Pescia G., Janecek P., Boillat E., Birkhäuser M.H., 2004. Prenatal Diagnosis, 24 (6) pp. 471-477.
[DOI][WoS][Pmid][serval:BIB_33705]
2003
 
Diabetes mellitus und Schwangerschaft: Screening und Therapie [Diabetes mellitus and pregnancy: screening and therapy].
Wunder D., Dürig P., 2003. Praxis, 92 (13) pp. 591-596.
[Pmid][serval:BIB_375644C9E262]
2001
 
Hormonale Kontrazeption bei Adoleszenten [Hormonal contraception for adolescents].
Butarelli M., Wunder D., Bodmer C., Birkhäuser M., 2001. Therapeutische Umschau. Revue Thérapeutique, 58 (9) pp. 534-540.
[Pmid][serval:BIB_F44877023200]
 
Hormonale Kontrazeption in der Perimenopause [Hormonal contraception in the perimenopause].
Butarelli M., Bodmer C., Wunder D., Birkhäuser M., 2001. Therapeutische Umschau. Revue Thérapeutique, 58 (9) pp. 555-563.
[Pmid][serval:BIB_2EB9FED72B64]
 
Serum-Mediane von Placentaprotein-Markern: Relevanz der Unterschiede zwischen spontanen und nach-in-vitro-Fertilisation eingetretenen Schwangerschaften für das fetale Trisomie-Screening.
Bersinger N.A., Chanson A., Crazzolara S., Hänggi W., Pescia G., Scheier M., Wunder D., 2001. Journal für Fertilität und Reproduktion, 11 (3) pp. 12-17.
[serval:BIB_18650]
2000
 
Combination antiretroviral therapy and duration of pregnancy.
European Collaborative Study, Swiss Mother Child HIV Cohort Study, Wunder Dorothea, Francioli Patrick, 2000. AIDS, 14 (18) pp. 2913-2920.
[WoS][Pmid][serval:BIB_3A99E1E4945E]
1994
 
Long-term follow-up of depression in seasonal affective disorder.
Leonhardt G., Wirz-Justice A., Kräuchi K., Graw P., Wunder D., Haug H.J., 1994. Comprehensive Psychiatry, 35 (6) pp. 457-464.
[WoS][Pmid][serval:BIB_0D381FE2060D]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University